MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)
Clinical trial NCT04129398 · COMPLETED
Trial details
- NCT number
- NCT04129398
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-27
- Primary completion
- 2022-10-06
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.